ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Entourage Health Corp

Entourage Health Corp (ENTG)

0.005
0.00
(0.00%)
Closed January 04 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.005
Bid
0.005
Ask
0.01
Volume
243,850
0.005 Day's Range 0.005
0.005 52 Week Range 0.02
Previous Close
0.005
Open
0.005
Last Trade
4000
@
0.005
Last Trade Time
Average Volume (3m)
192,462
Financial Volume
-
VWAP
-

ENTG Latest News

Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction

TORONTO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (the “Company” or “Entourage”) is pleased to announce that it has entered into a...

Entourage Health Reports Strong Third Quarter 2024 Financial Results

The Company achieved a total revenue of $13.6 million.Gross Profit Margins continue to demonstrate a solid performance with 30% growth year-over-year.SG&A achieves a significant reduction...

Entourage Health to Host Third Quarter 2024 Earnings Conference Call

TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...

Entourage Health Provides Company Update

TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...

Entourage Health Increases Senior Secured Credit Facility

TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...

Entourage Health Provides Company Update

TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...

Entourage Health Reports Second Quarter 2024 Financial Results

Total revenue of $12.2 million demonstrates the Company's solid momentum year over year and ongoing growth in the rapidly expanding bulk sales market.Entourage made a strong impact with new...

Entourage Health to Host Second Quarter 2024 Financial Results Call

TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...

Entourage Announces Results of 2024 Annual General Meeting of Shareholders

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning...

Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive Quarter

Total revenue of $16.4 million represents a 9% increase year-over-year and a 23% sequential increase from Q4 2023.Gross profit before fair value changes improved by 92% year-over-year, leading to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.005-500.010.010.0056350340.00551031CS
4-0.005-500.010.0150.0052178580.00692071CS
12-0.01-66.66666666670.0150.0150.0051924620.01010063CS
26-0.005-500.010.0150.0051156420.01082634CS
52-0.01-66.66666666670.0150.020.0051055480.01188397CS
156-0.085-94.44444444440.090.1350.0051051300.03520187CS
260-0.285-98.2758620690.290.310.0051328790.07024148CS

ENTG - Frequently Asked Questions (FAQ)

What is the current Entourage Health share price?
The current share price of Entourage Health is $ 0.005
What is the 1 year trading range for Entourage Health share price?
Entourage Health has traded in the range of $ 0.005 to $ 0.02 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MUST.HMust Capital Inc
$ 0.06
(200.00%)
165k
KUAI.PKua Investments Inc
$ 0.045
(125.00%)
14k
CRBKCarebook Technologies Inc
$ 0.095
(111.11%)
420.1k
CPLCopper Lake Resources Ltd
$ 0.01
(100.00%)
9k
VKG.HNorse Gold Corp
$ 0.02
(100.00%)
2.16k
TVITVI Pacific Inc
$ 0.005
(-50.00%)
11k
MTBMTB Metals Corp
$ 0.01
(-50.00%)
116.4k
ETUE2gold Inc
$ 0.005
(-50.00%)
10k
KOVOKovo+ Holdings Inc
$ 0.035
(-41.67%)
15k
PORPortofino Resources Inc
$ 0.01
(-33.33%)
349k
MATEBlockmate Ventures Inc
$ 0.41
(38.98%)
9.03M
DMDataMetrex AI Limited
$ 0.005
(0.00%)
4.48M
THRMTherma Bright Inc
$ 0.04
(14.29%)
3.45M
GPUSAlset AI Ventures Inc
$ 0.16
(-3.03%)
2.41M
SSESilver Spruce Resources Inc
$ 0.005
(0.00%)
2.14M

Discussion

View Full Feed
crescentmotor crescentmotor 5 minutes ago
Seems like a lot of silly effort for no impact on share price come Monday-Friday.

With AVXL's MAA being accepted and under review, a favorable/supportive peer review article about to be officially released in mass distribution, and presentations of OLE trial data at the prestigious JP
AVXL JPM
mauismart mauismart 7 minutes ago
I just bought a. 2000 Toyota echo with over 100k miles for only $1200 and she gets over 30 miles to the gallon. I saved my avxl share
AVXL
carvajal carvajal 7 minutes ago

Brian's ties to Brazil date back to 2021.

" style="font-size: 1em"#HUMBL continues to advance. Please do not mistake silence for weakness."

 
HMBL
shortridge3w shortridge3w 8 minutes ago
Regarding the 1.8 point difference of ADAS-cog13 between dosed and placebo, the worst estimate could be done by extending the dosed curve 4 months, which would result in 1 point increase. This can be verified with the open label extension data.
AVXL
Risk Risk 8 minutes ago
Yes Golf. I Agree, Just want to get out man break even if it's a possiblility???
Happy to hear you made it back on Quantum stocks.
AFFU
TURCH TURCH 8 minutes ago
Yup have Rr and krknf if u find any others let me know!


Regards
doccjc doccjc 8 minutes ago
Wonder if we'll get an update on Monday ?
First full week of trading since the India  human trials announcement 
Positive human trial results may cause the stock to run imo .
RDGL
theorysuit theorysuit 10 minutes ago
Immunomedics was $10B before Gilead bought them for Trodelvy. They paid $21B before it had FDA approval.

Wrong, IMMU already had accelerated approval in mTNBC by FDA, and had confirmatory data that was stopped early for hitting their pfs and OS endpoints to support full approval. A
NWBO
doccjc doccjc 11 minutes ago
Sure as hell feels different. Obgoing human trials , IDE about to be submitted .  We're about to find out if this works in humans as well as it does in animals. No reason it shouldn't .  Share price is about to take off imo . 
RDGL
StockItOut StockItOut 14 minutes ago
Bitcoin, for example, is not lawful money.

The Note is: money or shares or both. Standard.

You really are a nutjob.
XERI
againstallodds againstallodds 14 minutes ago
A/S tells you where JarHead is headed….
NBRI
blackhawks blackhawks 15 minutes ago
Curtain is still with us.

https://en.wikipedia.org/wiki/Jane_Curtin
getmoreshares getmoreshares 15 minutes ago
.0005 next!
KATX
StockItOut StockItOut 16 minutes ago
The Note is either/or you moron.
XERI
SSKILLZ1 SSKILLZ1 16 minutes ago
Mr. Sheep Picks

There will two Mr. Sheep this contest one with cash and one without. Hope this helps.
[pre]
38 Alias: MR. SHEEP

Symbol
1 $$
2 CCEL 4-3/4 Positions
3 ETCC
4 OPXS
5
ETCC VNDA
georgejjl georgejjl 16 minutes ago
Don't forger Ern Heaven from the Phase 2a trial.

https://www.youtube.com/watch?v=8orzf4UXNLA

Good luck and GOD bless,
AVXL
quester614 quester614 16 minutes ago
There is a reason the clause lawful money is in the Auctus loan. They were never going to sell 1 shares or OPTION. ANY DECENT LAWYER should know that a specific language is used for reasons in contracts.

LOLOLOLhttps://investorshub.advfn.com/uimage/uploads/2025/1/4/qwgpiScreenshot_20
XERI
Manspider Manspider 17 minutes ago
Foolish rabbit … tricks are for kids! :-D
ASII
jay_tee jay_tee 18 minutes ago
It's obvious you still believe in Santa if you really believe I'm a paid basher. I've never once bashed RNVA
RNVA
solong solong 18 minutes ago
Read all of the tweets from the company, they aren't going for Pink Current. Do you have any idea as to who is in charge? Read the company tweets.

They've laid out where this is heading and Pink Current is not the destination.
SYIN
imho imho 19 minutes ago
I have noticed that posts by Doc and Investor critiquing Blarcamisine, avoid comparisons to the MABs. They would be correct in stating that the MABs have nothing to do in assessing if Blarcamisine works (vs a placebo). That is the premise and the basis for their conclusions.

However,
AVXL

Your Recent History

Delayed Upgrade Clock